We are live on ! Find out more
EMR

Errol M. Rudman Portfolio holdings

AUM $148M
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$268M
AUM Growth
+$53M
Cap. Flow
+$32.9M
Cap. Flow %
12.29%
Top 10 Hldgs %
51.87%
Holding
53
New
10
Increased
9
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
CBPO
China Biologic Products Holdings, Inc.
CBPO
+$6.65M
2
JPM icon
JPMorgan Chase
JPM
+$6.24M
3
ADUS icon
Addus HomeCare
ADUS
+$4.21M
4
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
+$4.02M
5
WFC icon
Wells Fargo
WFC
+$3.43M

Top Sells

Rank Stock Value
1
BLD
TopBuild
BLD
+$4.23M
2
XRAY icon
Dentsply Sirona
XRAY
+$2.08M
3
ESPR
Esperion Therapeutics
ESPR
+$1.96M
4
CALM icon
Cal-Maine
CALM
+$1.52M
5
LAZ icon
Lazard
LAZ
+$1.49M

Sector Composition

Rank Sector Weight
1 Industrials 32.5%
2 Healthcare 26.43%
3 Financials 9.91%
4 Consumer Discretionary 7.8%
5 Technology 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLD
51
DELISTED
TopBuild
BLD
– –
-54,059
Closed -$4.23M
CALM icon
52
Cal-Maine
CALM
$4.43B
– –
-33,100
Closed -$1.52M
ESPR
53
DELISTED
Esperion Therapeutics
ESPR
– –
-50,000
Closed -$1.96M
1 2
3

Similar funds

HAM
Hillswick Asset Management Stamford, Connecticut $150M AUM 7.89% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
RMPT
Raytheon Master Pension Trust Waltham, Massachusetts $140M AUM 5.65% 1-Year Est. Return
QAM
Quantres Asset Management Cayman, Cayman Islands $138M AUM 11.79% 1-Year Est. Return
CWM
Catamount Wealth Management Westport, Connecticut $176M AUM 15.01% 1-Year Est. Return
RCA
Restructuring Capital Associates Stamford, Connecticut $115M AUM 20.18% 1-Year Est. Return
CI
Caerus Investors New York $183M AUM 0.18% 1-Year Est. Return
LS
Lattice Strategies Wayne, Pennsylvania $109M AUM 3.52% 1-Year Est. Return

Errol M. Rudman's Q3 2018 Portfolio in Review

As of Q3 2018, Errol M. Rudman held 53 positions worth $268M, up 25% from $215M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Errol M. Rudman deployed $32.9M of net new capital in Q3 2018, opening 10 new positions and adding to 9 existing holdings. Its largest new stake was JPMorgan Chase: 55,000 shares worth $6.21M.

By sector, the portfolio is most concentrated in Industrials at 33% of assets, down from 36% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dentsply Sirona, an estimated $2.08M trimmed.

  • Errol M. Rudman's largest Q3 2018 buy was JPMorgan Chase: 55,000 shares worth $6.21M.
  • Errol M. Rudman added most to China Biologic Products Holdings, Inc. in Q3 2018, an estimated $6.65M increase.
  • Errol M. Rudman's biggest Q3 2018 reduction was Dentsply Sirona, cutting an estimated $2.08M.
  • Errol M. Rudman fully exited TopBuild in Q3 2018, selling an estimated $4.23M.
  • Errol M. Rudman's ten largest holdings make up 52% of its $268M portfolio in Q3 2018.
  • Errol M. Rudman opened 10 new positions and closed 3 in Q3 2018.
  • Errol M. Rudman's portfolio value rose 25% quarter-over-quarter to $268M.

Based on Errol M. Rudman's 13F filing for Q3 2018, filed 14 Nov 2018.